Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Earp

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell LymphomaDeepti Telaraja, Yvette L Kasamon, Justin S Collazo, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 4, 2021
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology ConsiderationsXinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic SyndromesNina Kim, Kelly J Norsworthy, Sriram Subramaniam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutationGeoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell LymphomaDeepti Telaraja, Yvette L Kasamon, Justin S Collazo, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 4, 2021
Anti-SARS-CoV-2 Repurposing Drug Database: Clinical Pharmacology ConsiderationsXinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic SyndromesNina Kim, Kelly J Norsworthy, Sriram Subramaniam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutationGeoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Pageof 2